PhotoCure submits MAA

Norwegian photodynamic therapy company PhotoCure (OSE:PHO) submitted an MAA in New Zealand for its Metvix PDT therapy to treat basal cell carcinoma and actinic keratosis. PHO has also filed marketing ...